www.intelgenx.com Open in urlscan Pro
69.16.221.82  Public Scan

Submitted URL: http://intelgenx.com/
Effective URL: https://www.intelgenx.com/
Submission: On December 24 via api from US — Scanned from CA

Form analysis 2 forms found in the DOM

GET /search.html

<form id="mod-finder-searchform103" action="/search.html" method="get" class="form-search" role="search">
  <label for="mod-finder-searchword103" class="element-invisible finder m-search style1 headerfont">Search</label><input type="text" name="q" id="mod-finder-searchword103" class="search-query input-medium" size="25" value="" placeholder="Search ...">
</form>

Name: display-section1POST https://www.intelgenx.com/?chronoform=initiate-a-project&event=submit

<form action="https://www.intelgenx.com/?chronoform=initiate-a-project&amp;event=submit" method="post" name="display-section1" id="display-section1" data-id="display-section1" class="ui form G2-form" data-valloc="inline" enctype="multipart/form-data"
  data-dtask="send/self" data-result="replace/self" data-subanimation="1">
  <div class="ui segment" id="area_segment_29">
    <div class="ui grid">
      <div class="row equal width top aligned">
        <div class="column row1_column1">
          <div class="field  required"><input data-validationrules="{&quot;identifier&quot;:&quot;fname-main&quot;,&quot;rules&quot;:[{&quot;type&quot;:&quot;required&quot;,&quot;prompt&quot;:&quot;Name*&quot;}]}" data-validate="fname-main"
              placeholder="Name*" name="fname" id="fname" value="" type="text"></div>
          <div class="field  required"><input
              data-validationrules="{&quot;identifier&quot;:&quot;email-main&quot;,&quot;rules&quot;:[{&quot;type&quot;:&quot;required&quot;,&quot;prompt&quot;:&quot;Email*&quot;},{&quot;type&quot;:&quot;email&quot;,&quot;prompt&quot;:&quot;Email*&quot;},{&quot;type&quot;:&quot;maxLength[100]&quot;,&quot;prompt&quot;:&quot;Email*&quot;}]}"
              data-validate="email-main" placeholder="Email*" name="email" id="email" value="" type="text"></div>
          <div class="field  required"><input data-validationrules="{&quot;identifier&quot;:&quot;company-main&quot;,&quot;rules&quot;:[{&quot;type&quot;:&quot;required&quot;,&quot;prompt&quot;:&quot;Company*&quot;}]}" data-validate="company-main"
              placeholder="Company*" name="company" id="company" value="" type="text"></div>
          <div class="field "><input data-validationrules="{&quot;identifier&quot;:&quot;phone_number-main&quot;,&quot;optional&quot;:false,&quot;rules&quot;:[{&quot;type&quot;:&quot;number&quot;,&quot;prompt&quot;:&quot;Phone Number&quot;}]}"
              data-validate="phone_number-main" placeholder="Phone Number" name="phone_number" id="phone_number" value="" type="text"></div>
          <div class="field "><input placeholder="Country" name="country" id="country" value="" type="text"></div>
        </div>
        <div class="column row1_column3">
          <div class="field  required"><textarea data-validationrules="{&quot;identifier&quot;:&quot;message-main&quot;,&quot;rules&quot;:[{&quot;type&quot;:&quot;required&quot;,&quot;prompt&quot;:&quot;Tell Us More About Your Project *&quot;}]}"
              data-validate="message-main" rows="3" name="message" id="message" placeholder="Tell Us More About Your Project *" type="textarea" data-rows="3"></textarea></div>
          <div class="field  hidden"><label for="flag">flag</label>
            <input placeholder="" name="flag" id="flag" value="" type="text">
          </div>
          <div class="ui grid">
            <div class="row equal width top aligned">
              <div class="column row1_column1">
                <script src="https://hcaptcha.com/1/api.js" async="" defer=""></script>
                <div class="h-captcha" data-sitekey="6d2b1cb0-b36b-408f-ae66-6d17de3b70cd"><iframe
                    src="https://newassets.hcaptcha.com/captcha/v1/ccb766f/static/hcaptcha.html#frame=checkbox&amp;id=0clw5lqfjmxt&amp;host=www.intelgenx.com&amp;sentry=true&amp;reportapi=https%3A%2F%2Faccounts.hcaptcha.com&amp;recaptchacompat=true&amp;custom=false&amp;hl=en&amp;tplinks=on&amp;sitekey=6d2b1cb0-b36b-408f-ae66-6d17de3b70cd&amp;theme=light&amp;origin=https%3A%2F%2Fwww.intelgenx.com"
                    tabindex="0" frameborder="0" scrolling="no" title="Widget containing checkbox for hCaptcha security challenge" data-hcaptcha-widget-id="0clw5lqfjmxt" data-hcaptcha-response=""
                    style="width: 303px; height: 78px; overflow: hidden;"></iframe><textarea id="g-recaptcha-response-0clw5lqfjmxt" name="g-recaptcha-response" style="display: none;"></textarea><textarea id="h-captcha-response-0clw5lqfjmxt"
                    name="h-captcha-response" style="display: none;"></textarea></div>
              </div>
              <div class="column row1_column2"><button class="ui button blue c-btn1-blue" type="submit" name="button25" id="button25" value="" data-selections="0" data-message="Please make a selection from the list">Submit &gt;&gt;</button></div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
</form>

Text Content

TSX: IGX
TSX: IGX Sign Up

Powered by Translate
English
English French
 * Pharma Product
   *  * Back
      * Overview
      * RIZAPORT®
      * Tadalafil
      * Loxapine
      * Montelukast
 * Technologies
   *  * Back
      * Technologies
      * VersaFilm™
      * VetaFilm
      * VevaDermTM
 * Development
   *  * Back
      * Services
      * Adversa
 * Manufacturing
   *  * Back
      * Overview
      * Supply chain
      * Manufacturing & Packaging
 * Partnering
   *  * Back
      * Overview
      * Trade Shows
        *  * Back
           * 2019
           * 2018
           * 2017
      * BD Contacts
 * Contact Us
 * Governance
   *  * Back
      * Corporate Governance
      * Documents and Policies
 * Investors
   *  * Back
      * Overview
      * Stock Price
        *  * Back
           * OTCQX: IGXT
           * TSX-V: IGX
      * Regulatory Filings
        *  * Back
      * Events
        *  * Back
           * 2020
           * 2019
           * 2021
      * Investor Relations
      * Analyst Coverage
      * Webcast
      * Investor Presentations
      * Investor FAQs
 * Careers
 * About Us
   *  * Back
      * Management
      * Board of Directors
      * Scientific Advisory Board
 * Newsroom
   *  * Back
      * Press Release
        *  * Back
           * 2020
           * 2019
           * 2018
           * 2017
           * 2016
           * 2015
           * Archive
           * 2022
           * 2021
      * In the News
 * Sign Up
 * 
 * 
 * 

Pharma Product
Pharma Product
 
 * Back
 * Overview
   

 
TECHNOLOGIES
TECHNOLOGIES

IntelGenx’s Superior Film Technologies

 
 * Back
 * Technologies
 * VersaFilm®
 * VetaFilmTM
 * VevaDermTM

INVESTOR PRESENTATION

View our latest presentation

 

DOWNLOAD

Development
Development
 
 * Back
 * Services
 * Adversa®

 
Manufacturing
Manufacturing

IntelGenx’s highly skilled team provides technological expertise in scale-up,
technology transfer and manufacturing of pharmaceutical films.

 
 * Back
 * Overview
 * Supply chain
 * Manufacturing & Packaging

INVESTOR PRESENTATION

View our latest presentation

 

DOWNLOAD

Partnering
Partnering

 

 
 * Back
 * Overview
 * Trade Shows
 * BD Contacts

 
 * Back
   

Governance
Governance

 

 
 * Back
 * Corporate Governance
 * Documents and Policies

 
 * Back
   

Investors
Investors

 

 
 * Back
 * Overview
 * Stock Price
 * Regulatory Filings

 
 * Events
 * Investor Relations
 * Analyst Coverage

 
 * Webcast
 * Investor Presentations
 * Investor FAQs

Search
 


SUPERIOR FILM TECHNOLOGIES ADDRESSING UNMET MEDICAL NEEDS

Now trading on the TSX: IGX  Read More

The Therapeutic Advantages Of Oral Thin Film Delivery

Download



 


 LATEST NEWS

 View all news >

07

Dec

| IntelGenx Announces Collaboration with U...

SAINT LAURENT, Quebec, Dec. 07, 2022 (GLOBE NEWSWIRE) -- IntelGenx
Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx”), a leader in
pharmaceutical films, today announced a research...

22

Nov

| IntelGenx Receives FDA PDUFA Date for RI...

SAINT LAURENT, Quebec, Nov. 22, 2022 (GLOBE NEWSWIRE) -- IntelGenx
Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx"), a leader in
pharmaceutical films, today announced that the U.S. Food...

10

Nov

| IntelGenx Reschedules Third Quarter 2022...

SAINT LAURENT, Quebec, Nov. 10, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies
Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films,
today announced that its third quarter...

 


 IN THE NEWS

 View all news >

30

Oct

| IntelGenx And Heritage Cannabis Holdings...



08

Oct

| Oral Film Delivery Could Aid Psychedelic...



16

Sep

| IntelGenx inks double deals to develop o...




INTELGENX’S SUPERIOR FILM TECHNOLOGIES

CREATING NEXT GENERATION PHARMACEUTICAL PRODUCTS

 





ORAL FILMS

Rapidly disintegrating oral films easing drug administration without the need
for water





TRANSMUCOSAL FILMS

Buccal or sublingual films improving absorption, accelerating onset of action,
and reducing side effects





ORAL TOPICAL FILMS

Local topical films for extended release of mucoadhesive drug particles in the
oral cavity





TRANSDERMAL PATCHES

Prolonged duration of action while reducing the frequency of dosing and reducing
adverse effects



 

WE CARE FOR ANIMALS

When animals are healthy, humans are healthier too. We commit to making the
industry even better at improving both human and animal health.





 


OUR PARTNERS


 


WHY INTELGENX TECHNOLOGY

Learn More



INITIATE A PROJECT







flag
Submit >>



Terms of service | Privacy | Contact Us 
© 2022 Copyright - IntelGenx Corp.
Site & CMS By Sandman Media Inc


previousnextstart slideshow







ORIGINAL TEXT


Contribute a better translation

--------------------------------------------------------------------------------




This website uses cookies to ensure you get the best experience on our website.

I Understand